Reported Positive Data in First Pivotal Phase 3 Trial for Nyxol Eye Drops with Plans to Advance Towards NDA Submission and Commercialization in Reversal of Mydriasis Indication […]
● Compositions and Methods for Enhancing Anti-viral Therapies ●
[…]
Interview with Timothy Ko, CEO […]
Following the Meeting, Mr. Adrian Smith, Mr. Collin Kim, Mr. Ken Chung, Mr. Kosta Tsoutsis and Mr. Mike Collins will serve on the board of directors. […]
PurCann, a subsidiary of SiliCycle, is recognized for its unique expertise in the Extraction-Purification and commercialization of cannabinoids. […]
During the interview, Mr. Joyce discusses recent data-driven milestones that reinforce the potential for Sigyn Therapy™ to overcome the limitations of previous strategies to treat sepsis and other life-threatening inflammatory conditions. […]
The Company has generated approximately 134 tons of pressed filter cake PGM concentrate and delivered approximately 32.18 tons during 2020 […]
MONTREAL, Dec. 17, 2020 (GLOBE NEWSWIRE) — Innovative silicon solutions provider HPQ Silicon Resources Inc. (“HPQ” or “the Company”) (TSX-V: HPQ; FWB: UGE; Other OTC : URAGF), through its wholly – owned subsidiary, HPQ Nano Silicon Powders inc (“HPQ […]
Vancouver, British Columbia–(Newsfile Corp. – November 20, 2020) – ArcPacific Resources Corp. (TSXV: ACP) (“ACP” or the “Company“) is pleased to announce it has entered into a purchase and sale agreement dated November 17, 2020 (the “Purchase […]
*This represent HPQ NANO first ever nanopowders order* […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com